Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-12T02:44:27.660Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of Sertraline in Psychiatric Practice

Published online by Cambridge University Press:  16 April 2020

N. Zivlak - Radulovic ,
M. Miskovic ,
D. Zoric ,
T. Maglov  and
D. Ilic
N. Zivlak - Radulovic
Affiliation:
Clinic for Psychiatry Clinical Center Banjaluka, Banja Luka, Bosnia-Herzegovina
M. Miskovic
Affiliation:
Clinic for Psychiatry Clinical Center Banjaluka, Banja Luka, Bosnia-Herzegovina
D. Zoric
Affiliation:
Clinic for Psychiatry Clinical Center Banjaluka, Banja Luka, Bosnia-Herzegovina
T. Maglov
Affiliation:
Clinic for Psychiatry Clinical Center Banjaluka, Banja Luka, Bosnia-Herzegovina
D. Ilic
Affiliation:
Primary Health Care Center, Center for Menthal Health, Banja Luka, Bosnia-Herzegovina

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sertraline is an antidepressant of the third generation of the selective serotonin reuptake inhibitor (SSRI) class. It is simple to use and has a wide application in treating various psychiatric disorders, but with much less pronounced side effects.

The aim of this study is to establish the frequency and adverse effects in users of sertraline during clinical treatment.

The method of work was a prospective study which comprised 30 participants who came for a medical examination for the first time and who had a valid indication for drug suitability. The patients were observed during the following two control check-ups. The findings thus gathered were statistically analysed and shown on the graphs.

Conclusion:

The examination has shown that the possible side effects of sertraline are rare and mainly of temporary nature, and confirm the effectiveness and safety of sertraline in routine clinical practice.

Type
P01-115
Information
European Psychiatry , Volume 24 , Issue S1: 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract book , January 2009 , 24-E503
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.